Skip to main content
Caplight Logo









Symbiotic.blue

Symbiotic.blue

Private
LondonHealthcare & Life Scienceshttps://symbiotic.blue/

Last Round

Pre Seed

Jun 19, 2025

Company Overview

Symbiotic.blue is a biotechnology company that develops an artificial intelligence-driven drug discovery platform by combining generative AI with brain-inspired methodologies.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

AIDDAI-driven drug discoverytechbiounimolecular polypharmacyUniMPAI drug discoverygenerative AImulti-target therapeuticshierarchical feature bindingHFBdrug discovery platformin silico drug designcomputational biologyprecision medicinebiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Symbiotic.blue Comparables

Compare Symbiotic.blue with similar companies based on industry and business-model similarity.

Symbiotic.blue comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Harmonic Discovery
84%
PolarisQB
82%
Genesis Molecular AI
76%

Symbiotic.blue Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJun 19, 2025

Symbiotic.blue Filings

Explore SEC and related filing metadata, where available.

Symbiotic.blue filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Symbiotic.blue's valuation, stock price, and market status.

Is Symbiotic.blue a public or private company?

Symbiotic.blue is a private company.

What is the current stock price of Symbiotic.blue?

Symbiotic.blue is a private company with no public stock price. No recent secondary market data is available.

How much is Symbiotic.blue worth (valuation)?

Valuation information for Symbiotic.blue is not publicly available.

Can I buy Symbiotic.blue stock?

Symbiotic.blue shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Symbiotic.blue's last funding round?

Symbiotic.blue's most recent funding round was Pre Seed on June 19, 2025.

Who are the main investors in Symbiotic.blue?

Investor information for Symbiotic.blue is not publicly disclosed.

Will Symbiotic.blue IPO soon?

No public IPO plans have been announced for Symbiotic.blue.

How can I track Symbiotic.blue secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Symbiotic.blue's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Employee Range1
Year Founded2025
Last FundingJun 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?